Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis

Xinrui ZHENG; Yannan XU; Danyang WANG; Feifei XING; Mengyao ZONG; Shihao ZHANG; Junyi ZHAN; Wei LIU; Gaofeng CHEN; Jiamei CHEN; Ping LIU; Yongping MU

doi:10.12449/JCH240117

Volume 40 Issue 1

Jan. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(1): 96-103

PDF( 4389 KB)

Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis

DOI: 10.12449/JCH240117

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine；Institute of Liver Disease，Shanghai Institute of Traditional Chinese Medicine；Key Laboratory of Liver and Kidney Diseases （Ministry of Education）；Shanghai Key Laboratory of Traditional Chinese Medicine，Shanghai 201203，China

Research funding:

National Natural Science Foundation of China (81874390);

Shanghai Natural Science Foundation (21ZR1464100);

Special Project for Biomedical Science and Technology Support of the “Science and Technology Innovation Action Plan” of Shanghai Science and Technology Commission in 2022 (22S11901700);

Shanghai Key Specialty of Traditional Chinese Clinical Medicine (shslczdzk01201)

More Information

Corresponding author: MU Yongping， ypmu8888@126.com （ORCID： 0000-0002-6808-8243）
Received Date: 2023-04-24
Accepted Date: 2023-05-15
Published Date: 2024-01-23

Abstract

Abstract

Objective To investigate the effect of transplantation of bone marrow mesenchymal stem cells （BMSCs） co-cultured with bone marrow-derived M2 macrophages （M2-BMDMs）， named as BMSC^M2， on a rat model of liver cirrhosis induced by carbon tetrachloride （CCl₄）/2-acetaminofluorene （2-AAF）. Methods Rat BMDMs were isolated and polarized into M2 phenotype， and rat BMSCs were isolated and co-cultured with M2-BMDMs at the third generation to obtain BMSC^M2. The rats were given subcutaneous injection of CCl₄ for 6 weeks to establish a model of liver cirrhosis， and then they were randomly divided into model group （M group）， BMSC group， and BMSC^M2 group， with 6 rats in each group. A normal group （N group） with 6 rats was also established. Since week 7， the model rats were given 2-AAF by gavage in addition to the subcutaneous injection of CCl₄. Samples were collected at the end of week 10 to observe liver function， liver histopathology， and hydroxyproline （Hyp） content in liver tissue， as well as changes in the markers for hepatic stellate cells， hepatic progenitor cells， cholangiocytes， and hepatocytes. A one-way analysis of variance was used for comparison of continuous data between multiple groups， and the least significant difference t-test was used for further comparison between two groups. Results Compared with the N group， the M group had significant increases in the activities of serum alanine aminotransferase （ALT） and aspartate aminotransferase （AST）（P<0.01）； compared with the M group， the BMSC and BMSC^M2 groups had significant reductions in ALT and AST （P<0.01）， and the BMSC^M2 group had significantly better activities than the BMSC group （P<0.05）. Compared with the N group， the M group had significant increases in Hyp content and the mRNA and protein expression levels of alpha-smooth muscle actin （α-SMA） in the liver （P<0.01）； compared with the M group， the BMSC and BMSC^M2 groups had significant reductions in Hyp content and the expression of α-SMA（P<0.05）， and the BMSC^M2 group had a significantly lower level of α-SMA than the BMSC group （P<0.01）. Compared with the N group， the M group had significant increases in the mRNA expression levels of the hepatic progenitor cell markers EpCam and Sox9 and the cholangiocyte markers CK7 and CK19 （P<0.01） and significant reductions in the expression levels of the hepatocyte markers HNF-4α and Alb （P<0.01）； compared with the M group， the BMSC and BMSC^M2 groups had significant reductions in the mRNA expression levels of EpCam， Sox9， CK7， and CK19 （P<0.05） and significant increases in the mRNA expression levels of HNF-4α and Alb （P<0.05）， and compared with the BMSC group， the BMSC^M2 group had significant reductions in the mRNA expression levels of EpCam and CK19 （P<0.05） and significant increase in the expression level of HNF-4α （P<0.05）. Conclusion M2-BMDMs can enhance the therapeutic effect of BMSCs on CCl₄/2-AAF-induced liver cirrhosis in rats， which provides new ideas for further improving the therapeutic effect of BMSCs on liver cirrhosis.
- Liver Cirrhosis,
- Mesenchymal Stem Cells,
- Macrophages,
- Rats， Wistar

FullText(HTML)

References(31)

References

[1]	FREEMAN RB Jr, STEFFICK DE, GUIDINGER MK, et al. Liver and intestine transplantation in the United States, 1997-2006[J]. Am J Transplant, 2008, 8( 4 Pt 2): 958- 976. DOI: 10.1111/j.1600-6143.2008.02174.x.
[2]	ZHANG YT, LI YW, ZHANG LL, et al. Mesenchymal stem cells: Potential application for the treatment of hepatic cirrhosis[J]. Stem Cell Res Ther, 2018, 9( 1): 59. DOI: 10.1186/s13287-018-0814-4.
[3]	XIE RP, GU MQ, ZHANG FB, et al. Current status and prospect of surgical technique of liver transplantation[J]. Ogran Transplant, 2022, 13( 1): 105- 110. DOI: 10.3969/j.issn.1674-7445.2022.01.016. 谢闰鹏, 谷明旗, 张凤博, 等. 肝移植手术技术的现状和展望[J]. 器官移植, 2022, 13( 1): 105- 110. DOI: 10.3969/j.issn.1674-7445.2022.01.016.
[4]	XIA Q, SHA M. Progress and prospect of living donor liver transplantation[J]. Chin J Dig Surg, 2022, 21( 1): 39- 42. DOI: 10.3760/cma.j.cn115610-20211205-00622. 夏强, 沙朦. 活体肝移植的进展与展望[J]. 中华消化外科杂志, 2022, 21( 1): 39- 42. DOI: 10.3760/cma.j.cn115610-20211205-00622.
[5]	HUANG W, BHADURI A, VELMESHEV D, et al. Origins and proliferative states of human oligodendrocyte precursor cells[J]. Cell, 2020, 182( 3): 594- 608. DOI: 10.1016/j.cell.2020.06.027.
[6]	KHARAZIHA P, HELLSTRÖM PM, NOORINAYER B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial[J]. Eur J Gastroenterol Hepatol, 2009, 21( 10): 1199- 1205. DOI: 10.1097/MEG.0b013e32832a1f6c.
[7]	SUK KT, YOON JH, KIM MY, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial[J]. Hepatology, 2016, 64( 6): 2185- 2197. DOI: 10.1002/hep.28693.
[8]	ESMAEILZADEH A, OMMATI H, KOOSHYAR MM, et al. Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, A controlled clinical study[J]. Cell J, 2019, 21( 3): 268- 273. DOI: 10.22074/cellj.2019.6108.
[9]	JIA SS, LIU X, LI WY, et al. Peroxisome proliferator-activated receptor gamma negatively regulates the differentiation of bone marrow-derived mesenchymal stem cells toward myofibroblasts in liver fibrogenesis[J]. Cell Physiol Biochem, 2015, 37( 6): 2085- 2100. DOI: 10.1159/000438567.
[10]	JIAN X, WANG DY, XU YN, et al. Effect of polarized bone marrow-derived macrophage transplantation on the progression of CCl₄-induced liver fibrosis in rats[J]. J Clin Hepatol, 2021, 37( 12): 2830- 2837. DOI: 10.3969/j.issn.1001-5256.2021.12.020. 简迅, 王丹阳, 许燕楠, 等. 极化骨髓巨噬细胞移植对CCl₄诱导的肝纤维化大鼠模型的影响[J]. 临床肝胆病杂志, 2021, 37( 12): 2830- 2837. DOI: 10.3969/j.issn.1001-5256.2021.12.020.
[11]	XU YN, XU W, ZHANG X, et al. BM-MSCs overexpressing the Numb enhance the therapeutic effect on cholestatic liver fibrosis by inhibiting the ductular reaction[J]. Stem Cell Res Ther, 2023, 14( 1): 45. DOI: 10.1186/s13287-023-03276-w.
[12]	JAMALL IS, FINELLI VN, QUE HEE SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues[J]. Anal Biochem, 1981, 112( 1): 70- 75. DOI: 10.1016/0003-2697(81)90261-x.
[13]	MU YP, OGAWA T, KAWADA N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet[J]. Lab Invest, 2010, 90( 2): 245- 256. DOI: 10.1038/labinvest.2009.123.
[14]	PRADERE JP, KLUWE J, DE MINICIS S, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice[J]. Hepatology, 2013, 58( 4): 1461- 1473. DOI: 10.1002/hep.26429.
[15]	KARLMARK KR, WEISKIRCHEN R, ZIMMERMANN HW, et al. Hepatic recruitment of the inflammatory Gr1⁺ monocyte subset upon liver injury promotes hepatic fibrosis[J]. Hepatology, 2009, 50( 1): 261- 274. DOI: 10.1002/hep.22950.
[16]	VANNELLA KM, WYNN TA. Mechanisms of organ injury and repair by macrophages[J]. Annu Rev Physiol, 2017, 79: 593- 617. DOI: 10.1146/annurev-physiol-022516-034356.
[17]	ORECCHIONI M, GHOSHEH Y, PRAMOD AB, et al. Macrophage polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages[J]. Front Immunol, 2019, 10: 1084. DOI: 10.3389/fimmu.2019.01084.
[18]	ZHOU T, YUAN ZN, WENG JY, et al. Challenges and advances in clinical applications of mesenchymal stromal cells[J]. J Hematol Oncol, 2021, 14( 1): 24. DOI: 10.1186/s13045-021-01037-x.
[20]	NISHINA T, HOSHIKAWA KT, UENO Y. Current cell-based therapies in the chronic liver diseases[J]. Adv Exp Med Biol, 2018, 1103: 243- 253. DOI: 10.1007/978-4-431-56847-6_13.
[21]	SAITO Y, IKEMOTO T, TOKUDA K, et al. Effective three-dimensional culture of hepatocyte-like cells generated from human adipose-derived mesenchymal stem cells[J]. J Hepatobiliary Pancreat Sci, 2021, 28( 9): 705- 715. DOI: 10.1002/jhbp.1024.
[22]	LUO XY, MENG XJ, CAO DC, et al. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes[J]. Stem Cell Res Ther, 2019, 10( 1): 16. DOI: 10.1186/s13287-018-1122-8.
[23]	CHAI NL, ZHANG XB, CHEN SW, et al. Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats[J]. World J Gastroenterol, 2016, 22( 26): 6036- 6048. DOI: 10.3748/wjg.v22.i26.6036.
[24]	GHAFOURI-FARD S, NIAZI V, HUSSEN BM, et al. The emerging role of exosomes in the treatment of human disorders with a special focus on mesenchymal stem cells-derived exosomes[J]. Front Cell Dev Biol, 2021, 9: 653296. DOI: 10.3389/fcell.2021.653296.
[25]	FONDEVILA MF, FERNANDEZ U, HERAS V, et al. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis[J]. J Hepatol, 2022, 77( 1): 15- 28. DOI: 10.1016/j.jhep.2022.02.003.
[26]	NOVO E, MARRA F, ZAMARA E, et al. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells[J]. Gut, 2006, 55( 1): 90- 97. DOI: 10.1136/gut.2005.069633.
[27]	WU XP, SHU LL, ZHANG ZX, et al. Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells[J]. Adv Sci, 2021, 8( 11): e2003721. DOI: 10.1002/advs.202003721.
[28]	PENG JY, LI F, WANG J, et al. Identification of a rare Gli1⁺ progenitor cell population contributing to liver regeneration during chronic injury[J]. Cell Discov, 2022, 8( 1): 118. DOI: 10.1038/s41421-022-00474-3.
[29]	TARLOW BD, FINEGOLD MJ, GROMPE M. Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury[J]. Hepatology, 2014, 60( 1): 278- 289. DOI: 10.1002/hep.27084.
[30]	MISHRA L, BANKER T, MURRAY J, et al. Liver stem cells and hepatocellular carcinoma[J]. Hepatology, 2009, 49( 1): 318- 329. DOI: 10.1002/hep.22704.
[31]	CHEN JM, ZHANG X, XU Y, et al. Hepatic progenitor cells contribute to the progression of 2-acetylaminofluorene/carbon tetrachloride-induced cirrhosis via the non-canonical Wnt pathway[J]. PLoS One, 2015, 10( 6): e0130310. DOI: 10.1371/journal.pone.0130310.
[32]	YAGI K, KOJIMA M, OYAGI S, et al. Application of mesenchymal stem cells to liver regenerative medicine[J]. Yakugaku Zasshi, 2008, 128( 1): 3- 9. DOI: 10.1248/yakushi.128.3.

Relative Articles

[1]	Bo Lun, Zhang Qiong, Wang XiangXu, Pan Wei, Zhang HongMei. Role of the VEGF/VEGFR pathways in the development,progression,and treatment of cholangiocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(8): 1866-1869. doi: 10.3969/j.issn.1001-5256.2020.08.041
[2]	Yao YunHai, Luo Yan, Zhu JingLe, Gan JianHe, Zhao WeiFeng. Measurement and clinical significance of peripheral blood vascular endothelial growth factor in patients with liver cirrhosis and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1966-1969. doi: 10.3969/j.issn.1001-5256.2020.09.011
[3]	Li Yang, Shu DeJun, Peng CiJun, Feng ZanJie, Mei Yong, Xiong Kun. Effect of erythropoietin on the mRNA expression of apoptosis genes bcl-2 and bax in rats with fatty liver disease after hepatic ischemia-reperfusion injury[J]. Journal of Clinical Hepatology, 2019, 35(1): 157-160. doi: 10.3969/j.issn.1001-5256.2019.01.030
[4]	Li CunDi, Cao WeiYa, Wang Jian. Expression of vascular endothelial growth factor receptors and invasion and metastasis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(7): 1616-1620. doi: 10.3969/j.issn.1001-5256.2019.07.042
[5]	Liao WeiRong, Gu Chao, Zhang DaWei. Clinical efficacy of sorafenib in treatment of primary hepatic carcinoma and its effects on serum VEGFR-2 and PLGF levels[J]. Journal of Clinical Hepatology, 2018, 34(6): 1220-1224. doi: 10.3969/j.issn.1001-5256.2018.06.018
[6]	Wang Li, Shi Wei, Xue Jun, Pan CuiRan, Yao Min, Yao DengFu. Regulatory effect of abnormal expression of hypoxia- inducible factor- 1α on angiogenesis in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(2): 369-374. doi: 10.3969/j.issn.1001-5256.2017.02.037
[7]	Zhao Bin, Ma ZhenQi. Serum levels of adiponectin and ferritin and their clinical significance in patients with nonalcoholic fatty liver in Qinghai,China[J]. Journal of Clinical Hepatology, 2016, 32(10): 1955-1958. doi: 10.3969/j.issn.1001-5256.2016.10.028
[8]	Han Zhen, Sun HuanQin, Jiang Na, Liu Ning, Xu Jie, Sun JianPing, Zhang YongHong. Angiogenesis-related factors in various clinical stages of hepatitis B-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(6): 932-935. doi: 10.3969/j.issn.1001-5256.2015.06.025
[9]	Zheng Yan, Zhang ChunQing, Wang QiZhi, Huang HaiYan, Wang ZhiNa, Wei Yuan, Xu AnTao. Differential expression of OPN, VEGF-A, and HIF-1α and its clinical significance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(1): 58-61.
[10]	Zhu ChaoHui, Chen DongFeng, Ai ZhengLin, Yang Li, Min Min. Relationship between serum visfatin and serum adiponectin level and the pathology of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(7): 735-737+748.
[11]	Chen LiPing, Wu Yuan. Research progress on the role of the vascular endothelial dysfunction in the process of non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(2): 210-213.
[12]	Tang JianJun, Jiang Yong, Luo GuangHua, Yuan Bo. The protective effect of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats[J]. Journal of Clinical Hepatology, 2011, 27(12): 1308-1311.
[13]	Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166.
[14]	Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279.
[15]	Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361.
[16]	Huang MiaoZhen. Clinical study of the relationship about fatty liver lipid peroxides with tumor necrosis factor α and insulin-likegrowth factorl.[J]. Journal of Clinical Hepatology, 2006, 22(3): 211-212.
[19]	Deng JingSong, Wang Jie. The value of measuring blood velocity in right branch of portal vein and Doppler sonographic waveforms in right hepatic vein by CDFI on fatty liver disease[J]. Journal of Clinical Hepatology, 2005, 21(2): 106-107.
[20]	Zhou Hui, Ma YingJi, Yang BaoShan, Zhu SiHe. Clinical evaluation of serum vascular endothelial growth factor and Insulin-like growth factor-Ⅱ assay in the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2004, 20(2): 106-107.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(10)

Get Citation

PDF

XML

Article Metrics

Article views (652) PDF downloads(40)

Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis

DOI: 10.12449/JCH240117

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis

DOI: 10.12449/JCH240117

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content